NR565 ADVANCED PHARMACOLOGY
MIDTERM EXAM PREP QUESTIONS
AND VERIFIED ANSWERS |GRADE
A+|CHAMBERLAIN COLLEGE
1. Which pharmacokinetic process is most significantly affected by a drug that highly binds to
albumin in a patient with severe malnutrition and hypoalbuminemia?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Answer: A
Conceptual Explanation: Distribution is affected because fewer binding sites lead to a
higher free fraction of the drug, potentially increasing toxicity.
2. A patient is prescribed a drug that is a known substrate of the CYP3A4 enzyme. If they
begin consuming grapefruit juice daily, what is the most likely outcome?
A. Decreased drug efficacy due to rapid metabolism
B. No change in drug levels as grapefruit juice affects CYP2D6
C. Reduced absorption through the intestinal wall
,D. Increased serum drug levels and risk of toxicity
Answer: D
Conceptual Explanation: Grapefruit juice inhibits CYP3A4, leading to decreased
metabolism and increased serum levels of substrates.
3. In the context of pharmacodynamics, how does a non-competitive antagonist affect the
drug response curve?
A. Shifts the curve to the right without changing Emax
B. Reduces the maximum effect (Emax) regardless of agonist concentration
C. Shifts the curve to the left
D. Increases the potency of the agonist
Answer: B
Conceptual Explanation: Non-competitive antagonists bind irreversibly or to allosteric
sites, reducing the maximum possible response.
4. Which of the following describes the ‘First-Pass Effect’?
A. Renal filtration of drugs upon first entry into the kidney
B. The time it takes for a drug to reach its minimum effective concentration
C. The initial distribution of drug to highly perfused organs
D. Rapid inactivation of oral drugs by the liver before reaching systemic circulation
, Answer: D
Conceptual Explanation: The first-pass effect refers to hepatic metabolism of a drug when
absorbed from the gut before it enters systemic circulation.
5. A drug with a high therapeutic index (TI) is characterized by:
A. A narrow margin of safety requiring frequent monitoring
B. A high risk for drug-drug interactions
C. A large difference between the effective dose and the lethal dose
D. Rapid clearance from the bloodstream
Answer: C
Conceptual Explanation: A high therapeutic index indicates that the drug is relatively safe
because the toxic dose is much higher than the therapeutic dose.
6. According to the DEA, which schedule of controlled substances has the highest potential
for abuse but also has currently accepted medical uses?
A. Schedule I
B. Schedule IV
C. Schedule III
D. Schedule II
Answer: D
MIDTERM EXAM PREP QUESTIONS
AND VERIFIED ANSWERS |GRADE
A+|CHAMBERLAIN COLLEGE
1. Which pharmacokinetic process is most significantly affected by a drug that highly binds to
albumin in a patient with severe malnutrition and hypoalbuminemia?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Answer: A
Conceptual Explanation: Distribution is affected because fewer binding sites lead to a
higher free fraction of the drug, potentially increasing toxicity.
2. A patient is prescribed a drug that is a known substrate of the CYP3A4 enzyme. If they
begin consuming grapefruit juice daily, what is the most likely outcome?
A. Decreased drug efficacy due to rapid metabolism
B. No change in drug levels as grapefruit juice affects CYP2D6
C. Reduced absorption through the intestinal wall
,D. Increased serum drug levels and risk of toxicity
Answer: D
Conceptual Explanation: Grapefruit juice inhibits CYP3A4, leading to decreased
metabolism and increased serum levels of substrates.
3. In the context of pharmacodynamics, how does a non-competitive antagonist affect the
drug response curve?
A. Shifts the curve to the right without changing Emax
B. Reduces the maximum effect (Emax) regardless of agonist concentration
C. Shifts the curve to the left
D. Increases the potency of the agonist
Answer: B
Conceptual Explanation: Non-competitive antagonists bind irreversibly or to allosteric
sites, reducing the maximum possible response.
4. Which of the following describes the ‘First-Pass Effect’?
A. Renal filtration of drugs upon first entry into the kidney
B. The time it takes for a drug to reach its minimum effective concentration
C. The initial distribution of drug to highly perfused organs
D. Rapid inactivation of oral drugs by the liver before reaching systemic circulation
, Answer: D
Conceptual Explanation: The first-pass effect refers to hepatic metabolism of a drug when
absorbed from the gut before it enters systemic circulation.
5. A drug with a high therapeutic index (TI) is characterized by:
A. A narrow margin of safety requiring frequent monitoring
B. A high risk for drug-drug interactions
C. A large difference between the effective dose and the lethal dose
D. Rapid clearance from the bloodstream
Answer: C
Conceptual Explanation: A high therapeutic index indicates that the drug is relatively safe
because the toxic dose is much higher than the therapeutic dose.
6. According to the DEA, which schedule of controlled substances has the highest potential
for abuse but also has currently accepted medical uses?
A. Schedule I
B. Schedule IV
C. Schedule III
D. Schedule II
Answer: D
